KurzfristigMittelfristigLangfristigSignale

SELLAS Life Sciences [SLS]

Börse: NASDAQ
Sektor: Healthcare
Branche: Biotechnology
Zuletzt aktualisiert 23 Jun 2026 @ 13:34 (Exchange is open)
Letzter Kurs: $9.12 6.93%
0.61 (↑)
GaG Algo Score™
v1.0
Kurz
0.61 (↑)
Mittel
2.50 (↑)
Lang
1.94 (↑)
KAUF
59.18%
Rendite 32.32%
VERKAUF
64.00%
Rendite -26.16%

Statistiken

Heutiges Volumen 4.75M
Durchschnittsvolumen 7.50M
Marktkapitalisierung 1.22B
EPS $-0.0487 (Q1 | 2026-05-12)
Nächster Ergebnistermin ($-0.0500) 2026-08-11
Letzte Dividende $0.420 (2010-12-09)
KGV -39.66 (Sektor) 26.21 (Branche) 17.28
ATR14 $0.669 (8.31%)
Möglicher Tagesswing $7.72 - $8.38 (8.67%)

Unterstützungs- und Widerstandsniveaus

Linie

Pivot-Daten

Pivot-Statistik
Kennzahl Durchschnitt Median Std.-Abw.
Gewinn % 50.50% 30.17% 51.20%
Verlust % -18.88% -18.88% 6.11%
Dauer 16.0d 12d 11.5d
Gefundene Pivots gesamt 6
Gewinn-/Verlustphasen 5 (3 Gewinn / 2 Verlust)
Letzter Pivot Top @ $8.05 am 2026-06-18
Änderung seit letztem Pivot $0.00 (0.00%)
Nächste Pivot-Prognose Letzter Kurs: $9.12
Erwarteter nächster Typ Bottom
Erwarteter Preis (Durchschn.) $6.53
Erwarteter Preis (Median) $6.53
Erwarteter Preisbereich (~68%) $6.04 - $7.02
Änderung zum Durchschnittsziel $-2.59 (-28.41%)
Erwartetes Datum (Durchschn.) 2026-07-04
Erwarteter Datumsbereich (~68%) 2026-06-22 - 2026-07-15
Basis Based on 2 historical losses (Avg: -18.88%, Median: -18.88%, StdDev of Abs: 6.11%) and duration (Avg: 16.0 days, StdDev: 11.5 days)
Hinweis Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

SELLAS Life Sciences climbs 3.74%.

SELLAS Life Sciences (SLS) stock price soared on Thursday after the stock rose $0.290 (3.74%) from the previous session on very high volume. The stock moderately outperformed the market today, rising faster than the NASDAQ's 1.91% gain. With 14.75M shares traded, volume yesterday reached $118.72M. This was 10.07M shares more than the prior day. Compared to the 10-day average of 5.98M shares, volume was more than the average.

SELLAS Life Sciences signals

There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

SELLAS Life Sciences Support & Resistance Levels

The stock is approaching the closest resistance level at $8.33. approximately $0.280 (3.48%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $8.97. On a fall back there will be support at $6.53 The dis das resistance s16.53 -

SELLAS Life Sciences Evaluation

  • Kurz Score: 0.61
  • Mittel Score: 2.50
  • Lang Score: 1.94